Regulatory Environment and Impact Analysis- Sterile Packaging Market Standards & Regulations, Regional & National Regulatory Bodies - Market Analysis & Forecast to 2020

規制環境および影響分析: 無菌包装市場

◆タイトル:Regulatory Environment and Impact Analysis- Sterile Packaging Market Standards & Regulations, Regional & National Regulatory Bodies - Market Analysis & Forecast to 2020
◆商品コード:MAM-PK-4234
◆調査・発行会社:MarketsandMarkets
◆発行日:2016年4月15日
◆ページ数:124
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:包装
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"規制環境および影響分析: 無菌包装市場"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場概観、市場の動態、市場規模及び予測等の情報をお届けいたします。

MarketsandMarkets projects that the market for sterile medical packaging will grow from USD 26.55 Billion in 2015 to USD 35.07 Billion by 2020, at an estimated CAGR of 5.72%. The sterile medical packaging market has been growing in accordance with the growth in the packaging industry. Factors such as increasing aging population, growing demand from the healthcare sector, and the popularity of using reliable packaging are driving the demand for sterile medical packaging.
The growing demand in the sterile packaging market highlights the need to implement an efficient regulatory framework. The European regulatory framework is stronger, effective, and organized. Countries such as France, Germany, Italy, and the U.K. have been considered for the study. The EU has implemented standards & regulations such as Medical Device Directive, which is applicable in the European Union and eliminates the trade barrier and significantly improves the processes involved in the sterile medical packaging industry.

On the basis of key regions, the market for sterile medical packaging is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The Asia-Pacific region is projected to be the fastest growing region, by 2020. This is mainly due to emerging economies in China and India, coupled with rising consumer spending power and the growing middle-class population. The regulatory framework in the sterile packaging market is complex and varies from region to region. However, in order to avoid confusion among manufacturers and ease the trade barrier, continuous efforts are made to harmonize the multiple standards and regulations to form global standards.

The report studies and covers sterile packaging regulations and legislations in North America, Europe, Asia-Pacific, and RoW. The regions have been further studied based on laws prevalent in the top countries. The countries studied in the report include the U.S., Canada, Mexico, Germany, France, the U.K., Italy, China, Japan, India, Australia, Brazil, Argentina, and South Africa.

【レポートの目次】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.3.1 Periodization Considered for the Sterile Medical Packaging Market
1.4 Currency Considered for the Sterile Medical Packaging Market
1.5 Unit Considered for the Sterile Medical Packaging Market
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.1.1 Breakdown of Primaries By Company Type, Designation & Region
2.2 Factor Analysis
2.2.1 Introduction
2.2.2 Overview of Parent Industry
2.2.3 Demand-Side Analysis
2.2.3.1 Rising Population
2.2.3.1.1 Increase in the Middle-Class Population, 2009–2030
2.2.3.2 Increasing Urban Population
2.2.3.3 Developing Economies: Gdp (Purchasing Power Parity)
2.2.4 Supply-Side Analysis
2.2.4.1 Fluctuation in Raw Material Prices
2.2.4.2 Increasing Investment in Research & Development to Develop Innovative Technologies
2.3 Market Size Estimation
2.4 Market Breakdown & Data Triangulation
2.5 Research Assumptions & Limitations
2.5.1 Assumptions
2.5.2 Limitations

3 Executive Summary (Page No. – 29)
3.1 Introduction
3.2 Regulatory Scenario
3.2.1 Regulatory Framework in North America
3.2.2 Regulatory Framework in Asia-Pacific
3.2.3 Regulatory Framework in Europe
3.2.4 Regulatory Framework in RoW
3.3 Medical Device Approval Process in Key Countries
3.4 Impact Analysis
3.4.1 Case Study: Medical Device Recall & Its Impact
3.4.2 Need for Harmonization of Global Standards & Regulations

4 Market Overview of Sterile Medical Packaging (Page No. – 40)
4.1 Introduction
4.2 Evolution
4.3 Market Dynamics
4.3.1 Drivers
4.3.1.1 Increased Health Awareness
4.3.1.2 Growing Demand From Healthcare Industry
4.3.1.3 Aging Population
4.3.2 Restraints
4.3.2.1 Stringent Regulations
4.3.3 Opportunities
4.3.3.1 New Product Development and Continuous Innovations in Pharmaceuticals
4.3.3.2 Developing New Sustainable Packaging Options
4.3.4 Challenges
4.3.4.1 Maintaining Medical Packaging Integrity
4.3.4.2 Rise in Healthcare Cost
4.4 Sterile Medical Package Development
4.5 Functions of A Sterile Medical Package
4.5.1 Protection
4.5.2 Ease of Use
4.5.3 Identification
4.5.4 Processability
4.5.5 Special Applications

5 International Governing Bodies (Page No. – 49)
5.1 Introduction
5.2 American Society for Testing and Materials (ASTM)
5.2.1 ASTM Committee D10
5.2.1.1 D10.13
5.2.1.2 D10.19
5.2.1.3 D10.27
5.2.1.4 D10.32
5.2.2 ASTM Committee F02
5.2.2.1 F02.10
5.2.2.2 F02.15
5.2.2.3 F02.20
5.2.2.4 F02.40
5.2.2.5 F02.50
5.3 International Organization of Standardization (ISO)
5.3.1 Developing ISO Standards
5.3.1.1 Preliminary Stage
5.3.1.2 Proposal Stage
5.3.1.3 Preparatory Stage
5.3.1.4 Committee Stage
5.3.1.5 Enquiry Stage
5.3.1.6 Approval Stage
5.3.1.7 Publication Stage
5.3.2 Standards Related to Sterile Medical Packaging
5.3.2.1 ISO 16775
5.3.2.2 ISO 11607
5.3.2.2.1 Application
5.3.2.2.2 Limitation
5.3.2.3 ISO 11607-1
5.3.2.4 ISO 11607-2
5.4 U.S. Food and Drug Administration (FDA)
5.5 International Medical Device Regulatory Forum (IMDRF)

6 Regulatory Framework for Sterile Medical Packaging in North America (Page No. – 66)
6.1 North America
6.2 North America: Sterile Medical Packaging Market Size, By Country
6.2.1 U.S.
6.2.2 Key Governing Bodies in the U.S.
6.2.2.1 FDA
6.2.2.1.1 Overview
6.2.2.1.2 Responsibilities
6.2.3 Canada
6.2.4 Key Governing Bodies in Canada
6.2.4.1 Health Canada (HC)
6.2.4.1.1 Overview
6.2.4.1.2 Responsibilities
6.2.5 Mexico
6.2.6 Key Governing Bodies in Mexico
6.2.6.1 Federal Commission for the Protection Against Sanitary Risk (COFEPRIS)
6.2.6.1.1 Overview
6.2.6.1.2 Responsibilities

7 Regulatory Framework for Sterile Medical Packaging in Europe (Page No. – 72)
7.1 Europe
7.2 Europe: Sterile Medical Packaging Market Size, By Country
7.3 Governing Bodies in Europe
7.3.1 European Committee for Standardization (CEN)
7.3.1.1 Overview
7.3.1.2 Standards Developed By CEN
7.3.1.2.1 Harmonization of En 868-1 and ISO 11607
7.3.1.2.2 En 868-2:2009
7.3.1.2.3 En 868-3:2009
7.3.1.2.4 En 868-4:2009
7.3.1.2.5 En 868-5:2009
7.3.1.2.6 En 868-6:2009
7.3.1.2.7 En 868-7:2009
7.3.1.2.8 En 868-8:2009
7.3.1.2.9 En 868-9:2009
7.3.1.2.10 En 868-10:2009
7.3.2 Sterile Barrier Association (SBA)
7.3.2.1 Overview
7.3.2.2 SBA Member Categories
7.3.2.3 Administering Activities
7.4 Medical Device Regulations in Europe
7.4.1 Introduction
7.4.2 Medical Device Directive (93/42/EEC)
7.5 Impact of Medical Device Regulations in Europe
7.5.1 CE Marking- A Gateway to Access European Market
7.5.2 Impact of Harmonization Between En and ISO
7.6 Key Countries in Europe
7.6.1 Germany
7.6.2 Key Governing Bodies in Germany
7.6.2.1 Federal Ministry of Health
7.6.2.1.1 Overview
7.6.2.1.2 Administering Activities
7.6.2.2 German Institute for Standardization (DIN)
7.6.2.2.1 Overview
7.6.2.2.2 Organizational Structure
7.6.2.2.3 Administering Activities
7.6.3 U.K.
7.6.4 Key Governing Bodies in the U.K.
7.6.4.1 Medicines and Healthcare Products Regulatory Agency (MHRA)
7.6.4.1.1 Overview
7.6.4.1.2 Responsibilities
7.6.4.2 Department of Health (DH)
7.6.4.2.1 Overview
7.6.4.2.2 Responsibilities
7.6.4.3 Association of British Healthcare Industries (ABHI)
7.6.4.3.1 Overview
7.6.4.3.2 Responsibilities
7.6.4.4 The British Standards Institution (BSI)
7.6.4.4.1 Overview
7.6.4.4.2 Responsibilities
7.6.5 France
7.6.6 Key Governing Bodies in France
7.6.6.1 National Agency for the Safety of Medicine and Health Products (ANMS)
7.6.6.1.1 Overview
7.6.6.1.2 Responsibilities
7.6.7 Italy
7.6.8 Key Governing Bodies in Italy
7.6.8.1 Ministry of Health (MOH)
7.6.8.1.1 Overview
7.6.8.1.2 Responsibilities
7.6.8.2 Italian Medicines Agency
7.6.8.2.1 Overview
7.6.8.2.2 Responsibilities

8 Regulatory Framework for Sterile Medical Packaging in Asia-Pacific (Page No. – 104)
8.1 Asia-Pacific
8.2 Asia-Pacific: Sterile Medical Packaging Market Size, By Country
8.2.1 China
8.2.2 Key Governing Bodies in China
8.2.2.1 China Food and Drug Administration (CFDA)
8.2.2.1.1 Overview
8.2.2.1.2 Responsibilities
8.2.3 Japan
8.2.4 Key Governing Bodies in Japan
8.2.4.1 Ministry of Health, Labor and Welfare (MHLW)
8.2.4.1.1 Overview
8.2.4.1.2 Responsibilities
8.2.5 India
8.2.6 Key Governing Bodies in India
8.2.6.1 CENtral Drugs Standard Control Organization (CDSCO)
8.2.6.1.1 Overview
8.2.6.1.2 Responsibilities
8.2.7 Australia
8.2.8 Key Governing Bodies in Australia
8.2.8.1 Therapeutic Goods Administration (TGA)
8.2.8.1.1 Overview
8.2.8.1.2 Responsibilities

9 Regulatory Framework for Sterile Medical Packaging in RoW (Page No. – 111)
9.1 RoW
9.2 RoW: Sterile Medical Packaging Market Size, By Country
9.2.1 Brazil
9.2.2 Key Governing Bodies in Brazil
9.2.2.1 National Health Surveillance Agency (ANVISA)
9.2.2.1.1 Overview
9.2.2.1.2 Responsibilities
9.2.3 Argentina
9.2.4 Key Governing Bodies in Argentina
9.2.4.1 National Administration of Drugs, Foodstuffs, and Medical Technology (ANMAT)
9.2.4.1.1 Overview
9.2.4.1.2 Responsibilities
9.2.5 South Africa
9.2.6 Key Governing Bodies in South Africa
9.2.6.1 Medicines Control Council (MCC)
9.2.6.1.1 Overview
9.2.6.1.2 Responsibilities

10 Appendix (Page No. – 116)
10.1 Insights of Industry Experts
10.2 Discussion Guide
10.3 Introducing RT: Real Time Market Intelligence
10.4 Available Customizations
10.5 Related Reports

List of Tables (33 Tables)

Table 1 Asia-Pacific: Urbanization Prospects
Table 2 Technical Subcommittees
Table 3 Technical Subcommittees
Table 4 Annex
Table 5 ISO 11607-1
Table 6 ISO 11607-2
Table 7 North America: Sterile Medical Packaging Market Size, By Country, 2013–2020 (USD Million)
Table 8 North America: Sterile Medical Packaging Market Size, By Country, 2013–2020 (Million Units)
Table 9 Europe: Sterile Medical Packaging Market Size, By Country, 2013-2020 (USD Million)
Table 10 Europe: Sterile Medical Packaging Market Size, By Country, 2013-2020 (Million Units)
Table 11 En 868-2:2009
Table 12 Implementation of En 868-2:2009 in European Countries
Table 13 En 868-3:2009
Table 14 Implementation of En 868-3:2009 in European Countries
Table 15 En 868-4:2009
Table 16 Implementation of En 868-4:2009 in European Countries
Table 17 En 868-5:2009
Table 18 Implementation of En 868-5:2009 in European Countries
Table 19 En 868-6:2009
Table 20 Implementation of En 868-6:2009 in European Countries
Table 21 En 868-7:2009
Table 22 Implementation of En 868-7:2009 in European Countries
Table 23 En 868-8:2009
Table 24 Implementation of En 868-8:2009 in European Countries
Table 25 En 868-9:2009
Table 26 Implementation of En 868-9:2009 in European Countries
Table 27 En 868-10:2009
Table 28 Implementation of En 868-10:2009 in European Countries
Table 29 Standards Published By Na 063-04-04 Aa
Table 30 Asia-Pacific: Sterile Medical Packaging Market Size, By Country, 2013–2020 (USD Million)
Table 31 Asia-Pacific: Sterile Medical Packaging Market Size, By Country, 2013–2020 (Million Units)
Table 32 RoW: Sterile Medical Packaging Market Size, By Country, 2013–2020 (USD Million)
Table 33 RoW: Sterile Medical Packaging Market Size, By Country, 2013–2020 (Million Units)

List of Figures (39 Figures)

Figure 1 Global Population Projected to Reach 9.5 Billion By 2050
Figure 2 Middle-Class Population, 2009-2030
Figure 3 Projected GDP Per Capita, By Country
Figure 4 Fluctuations in Price of Natural Gas From 2008 to 2015
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 North America Dominated the Sterile Medical Packaging Market in 2014
Figure 8 Medical Devices Approval Process in Europe
Figure 9 Medical Devices Approval Process in China
Figure 10 Medical Devices Approval Process in Australia
Figure 11 Process to Supply Imported Medical Devices in Australia
Figure 12 Medical Devices Approval Process in Japan
Figure 13 Medical Devices Approval Process in Brazil
Figure 14 Reasons for Medical Device Product Recalls
Figure 15 Evolution of Sterile Medical Packaging
Figure 16 Sterile Medical Packaging Market Dynamics
Figure 17 Revenue Generated By Pharmaceuticals and Medicines in the U.S.
Figure 18 Global Aging Population, 2010-2015
Figure 19 Number of Recalls, 2010-2012
Figure 20 Spending on Retail Prescription Drugs
Figure 21 ISO Standards Portfolio, By Sector, 2014
Figure 22 Development Process for ISO Standards
Figure 23 Medical Device Circle
Figure 24 Medical Devices Approval Process By FDA
Figure 25 FDA: Organization Chart
Figure 26 Health Canada: Organization Chart
Figure 27 Federal Commission for the Protection Against Sanitary Risk: Organization Structure
Figure 28 Federal Ministry of Health: Organization Chart
Figure 29 Medicines and Healthcare Products Regulatory Agency: Organizational Structure
Figure 30 Department of Health: Organization Chart
Figure 31 Association of British Healthcare Industries: Organization Structure
Figure 32 The British Standards Institution: Organization Structure
Figure 33 National Agency for the Safety of Medicine and Health Products: Organization Chart
Figure 34 Ministry of Health: Organization Structure
Figure 35 Italian Medicines Agency: Organization Chart
Figure 36 Ministry of Health, Labor and Welfare: Organization Structure
Figure 37 Central Drugs Standard Control Organization: Organization Structure
Figure 38 Therapeutic Goods Administration: Organization Structure
Figure 39 Medicines Control Council: Organization Structure

【レポートのキーワード】

無菌包装、滅菌包装、規制環境

★調査レポート[規制環境および影響分析: 無菌包装市場] ( Regulatory Environment and Impact Analysis- Sterile Packaging Market Standards & Regulations, Regional & National Regulatory Bodies - Market Analysis & Forecast to 2020 / MAM-PK-4234) 販売に関する免責事項
[規制環境および影響分析: 無菌包装市場] ( Regulatory Environment and Impact Analysis- Sterile Packaging Market Standards & Regulations, Regional & National Regulatory Bodies - Market Analysis & Forecast to 2020 / MAM-PK-4234) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆